본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Others

[SEDIA] Asanté ® HIV-1 Rapid Recency ® Assay

Cat-No. 1130-020



SEDIA Biosciences Coporation은 감염병 진단과 공중보건 모니터링을 위한 신속 진단키트 및 샘플 수집 기술을 개발하는 미국 바이오 진단 기업입니다.





제품 설명


Human Hereditary hemochromatosis protein (HFE) Elisa Kit




제품 번호


EK712624




제품 특징


A rapid, 20 minute in vitro immunoassay that differentiates recent from long-term HIV-1 infections for real time surveillance of new HIV-1 infections and the estimation of HIV-1 incidence rates in a population.* The assay can be used with blood (both venous and fingerstick), serum, or plasma specimens as either a laboratory or point-of-collection test.

For Research Use Only: Not for use in diagnostic procedures.


Easy to Use

The Asanté ® HIV-1 Rapid Recency ® Assay is faster, more cost effective and simpler to use than conventional HIV-1 incidence lab assays.

Add a loopful of specimen and the Test Strip to the Sample Buffer to begin the assay.

Low False Recency Rate

Low False Recency Rate

False recency rate comparable to the Sedia ® HIV-1 Limiting Antigen (LAg)-Avidity EIA laboratory assay.*

*Parek B, Detorio M, Shanmugam V, et al. Performance evaluation of Asanté ® HIV-1 Rapid Recency Assay for HIV diagnosis and detection of recent infection: Potential for surveillance and prevention. 9th IAS Conference on HIV Science. Paris. 2017. #TUPEC0849

Convenient

No laboratory infrastructure necessary. This enables field testing and collection of recency data in areas that are resource constrained.

Asante-HIV-1-Rapid-Recency-Assay-Kit-2


Catalog NumberDescription
1130-020Asanté ® HIV-1 Rapid Recency ® Assay, 20 Tests, For Research Use Only
1130-100Asanté ® HIV-1 Rapid Recency ® Assay, 100 Tests, For Research Use Only
READERFor additional details regarding the Asanté ® Test Strip Reader contact us today!

PRODUCT SPECIFICATIONS

Summary of Specifications
Assay Time20 minutes
Processing Temperature15° to 37°C (59° to 98.6°F)
Storage Temperature2° to 30°C (35.6° to 86°F)
Specimen TypeHuman whole blood, plasma (in EDTA or ACD anticoagulants), or serum
Specimen VolumeOne loopful or 5 µL if using pipette
Result Line 1Control; ensures proper functioning of the test
Result Line 2Verification; ensures exclusion of HIV negative specimens
Result Line 3LT/R; differentiates recent from long term infection
Custom AntigenCustom, multi-clade CDC “rIDR-M” HIV-1 gp41 antigen that provides for reduced HIV-1 subtype bias
Mean Duration of Recent InfectionApproximately 180 days*
U.S. CDC QualifiedEach lot is performance tested by the U.S. Centers for Disease Control prior to market release
Tests per KitAvailable in configurations of 20 tests or 100 tests per kit
For Research Use OnlyNot for use in diagnostic procedures, RUO products are not to be used for diagnostic purposes, patient management, clinical purposes, or for investigational use within the U.S.




SEDIA Biosciences Coporation의 모든 제품을 만나 보세요!


Asanté® Rapid Point-of-Care Assays

Asanté® HIV-1 Rapid Recency®

Asanté® HIV-1/2 Oral Fluid Test


Sedia® HIV Lab Based Products

SEDIA® HIV-1 Lag-Avidity EIA




SEDIA Biosciences Corpoartion - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"